| DC Field | Value | Language |
|---|
| dc.contributor.author | Khokhlov, A. L. | - |
| dc.contributor.author | Yaichkov, I. I. | - |
| dc.contributor.author | Shetnev, A. A. | - |
| dc.contributor.author | Korsakov, M. K. | - |
| dc.contributor.author | Volkhin, N. N. | - |
| dc.date.accessioned | 2025-01-24T07:09:06Z | - |
| dc.date.available | 2025-01-24T07:09:06Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | The evaluation of pharmacokinetic parameters of 4-(5-methyl-1,3,4-oxadiazole-2-yl)- benzenesulfonamide and its metabolites in rat plasma / A.L. Khokhlov, I.I. Yaichkov, A.A. Shetnev [et al.] // Research Results in Pharmacology. - 2024. - Vol.10, №4.-P. 67-76. - Doi: 10.18413/rrpharmacology.10.523. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/64411 | - |
| dc.description.abstract | 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide (ODASA) is a new pharmacologically active compound, which is capable of reducing intraocular pressure by inhibiting carbonic anhydrase II | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | intraocular pressure | ru |
| dc.subject | plasma | ru |
| dc.subject | stabilization | ru |
| dc.subject | validation | ru |
| dc.subject | pharmacokinetics | ru |
| dc.subject | bioavailability | ru |
| dc.subject | rats | ru |
| dc.subject | carbonic anhydrase II inhibitor | ru |
| dc.subject | Nhydroxysulfonamide | ru |
| dc.title | The evaluation of pharmacokinetic parameters of 4-(5-methyl-1,3,4-oxadiazole-2-yl)- benzenesulfonamide and its metabolites in rat plasma | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 4
|
